Abstract
Advances in the cloud technology for secured distributed data storage, modern techniques for machine learning (ML), and access to large populations through mobile apps provide a unique opportunity for the healthcare industry professionals in the areas of early screening and medical diagnostics for certain diseases. This research study demonstrates the potential of ML using convolutional neural networks (CNN) for medical diagnostics of skin melanoma. Specifically, a comparison is presented between a shallow CNN (3-layers) with Resnet50 (50-layers) to classify open datasets of skin melanoma images as malignant or benign. Various ML performance metrics such as accuracy, recall, precision and receiver operating characteristic (ROC) are presented to recommend a deep learning model for the mobile app. Also, a novel framework is proposed for the scalability and adoption of ML-based medical diagnostics by large masses as a mobile app running on data-secure cloud platform. Using the open datasets, it is shown that skin cancer can be accurately diagnosed with a mobile phone app while maintaining patient privacy and data security.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at (i) https://www.kaggle.com/datasets/nodoubttome/skin-cancer9-classesisic, and (ii) https://www.kaggle.com/datasets/kmader/skin-cancer-mnist-ham10000
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
